Furthermore, weight loss injections are typically reserved for individuals with a BMI of 30 or above, or a BMI of 27 with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol levels
May 2026: A May 1, 2026 update reported that the federal GLP-1 multidistrict litigation now includes 3,636 pending cases, with Mounjaro claims still making up a large share of the docket
However, everyones weight loss journey looks different, so your provider will recommend a medication for your needs during your initial consultation
Bellwether trials provide early insight into how juries may respond to recurring evidence and testimony, which can influence broader settlement discussions
Both are popular for their effectiveness in managing type 2 diabetes and weight loss